Retour
35
Fourchette du Jour
12,91 €
13,44 €
Fourchette 52 Semaines
12,50 €
21,89 €
Volume
595 493
Moyenne 50J / 200J
15,68 €
/
16,73 €
Clôture Précédente
12,79 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -30,3 | 0,4 |
| P/B | 3,2 | 2,9 |
| ROE % | -11,0 | 3,8 |
| Net Margin % | -9,4 | 3,9 |
| Rev Growth 5Y % | 22,2 | 10,0 |
| D/E | 0,0 | 0,2 |
Points Clés
Revenue grew 22,18% annually over 5 years — strong growth
Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -9,09M
Capital efficient — spends only 4,19% of revenue on capex
Croissance
Revenue Growth (5Y)
22,18%
Revenue (1Y)20,19%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-10,98%
ROIC-9,37%
Net Margin-9,41%
Op. Margin-11,11%
Sécurité
Debt / Equity
0,01
Current Ratio8,55
Interest Coverage-4,23
Valorisation
P/E Ratio
-30,34
P/B Ratio3,23
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20,19% | Revenue Growth (3Y) | 20,28% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 22,18% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 200,93M | Net Income (TTM) | -18,91M |
| ROE | -10,98% | ROA | -7,93% |
| Gross Margin | 79,57% | Operating Margin | -11,11% |
| Net Margin | -9,41% | Free Cash Flow (TTM) | -9,09M |
| ROIC | -9,37% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 8,55 |
| Interest Coverage | -4,23 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -30,34 | P/B Ratio | 3,23 |
| P/S Ratio | 2,86 | PEG Ratio | 1,10 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 573,71M | Enterprise Value | 532,59M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 200,93M | 167,18M | 138,89M | 106,41M | 90,15M |
| Net Income | -18,91M | -30,91M | -43,34M | -61,26M | -56,57M |
| EPS (Diluted) | -0,44 | -0,75 | -1,13 | -1,79 | -1,71 |
| Gross Profit | 159,88M | 132,12M | 109,42M | 90,70M | 79,72M |
| Operating Income | -22,33M | -35,25M | -46,93M | -59,61M | -51,67M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 238,56M | 230,44M | 230,43M | 157,55M | 190,51M |
| Total Liabilities | 61,02M | 63,47M | 61,05M | 59,25M | 56,09M |
| Shareholders' Equity | 177,53M | 166,96M | 169,38M | 98,30M | 134,42M |
| Total Debt | 1,12M | 37,48M | 38,99M | 39,43M | 40,48M |
| Cash & Equivalents | 42,24M | 34,95M | 33,27M | 20,72M | 63,42M |
| Current Assets | 216,12M | 207,78M | 211,39M | 137,61M | 175,87M |
| Current Liabilities | 25,28M | 27,13M | 23,46M | 21,18M | 16,89M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#98 of 146
Activité Récente
Entré
Full Throttle
Mar 24, 2026